Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Nutrition ; 70: 110595, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31739173

RESUMO

OBJECTIVES: The aims of this study were to determine vitamin D status (serum 25-hydroxyvitamin D3 [s-25(OH)D3]) and examine possible associations between vitamin D status and vitamin D-rich dietary sources, sun exposure, and body mass index in preschool children ages 4 to 6 y. METHODS: This is a cross-sectional study based on baseline data (collected in January-February 2015) from the two-armed randomized controlled trial Fish Intervention Studies-KIDS (FINS-KIDS) conducted in Bergen, Norway. S-25(OH)D3 concentration was determined by liquid chromatography-tandem mass spectrometry. Information regarding habitual dietary intake, recent sun vacations, and body mass index were assessed with questionnaires answered by the children's caregivers. RESULTS: The children (n = 212) had a mean (standard deviation) s-25(OH)D3 of 60.7 (13.8) nmol/L; 18.9% had s-25(OH)D3 ≤50 nmol/L. In logistic regression models, non-overweight versus overweight status was inversely associated with s-25(OH)D3 ≤50 nmol/L (odds ratio: 0.41; 95% confidence interval, 0.18-0.95; P = 0.037). Non-sun versus sun vacations were associated with s-25(OH)D3 ≤75 nmol/L (odds ratio: 5.33; 95% confidence interval, 1.93-14.77; P = 0.001). CONCLUSIONS: The majority of the preschool children (81%) had s-25(OH)D3 >50 nmol/L. Children with overweight status had an increased risk of s-25(OH)D3 ≤50 nmol/L, and children who had not been on sun vacations were at a greater risk of s-25(OH)D3 ≤75 nmol/L.


Assuntos
Calcifediol/sangue , Dieta/estatística & dados numéricos , Obesidade Infantil/sangue , Deficiência de Vitamina D/epidemiologia , Vitamina D/análise , Índice de Massa Corporal , Criança , Pré-Escolar , Estudos Transversais , Dieta/efeitos adversos , Feminino , Humanos , Modelos Logísticos , Masculino , Noruega/epidemiologia , Estado Nutricional , Obesidade Infantil/complicações , Ensaios Clínicos Controlados Aleatórios como Assunto , Estações do Ano , Luz Solar , Deficiência de Vitamina D/sangue , Deficiência de Vitamina D/etiologia
2.
Lipids ; 51(1): 61-73, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26552397

RESUMO

The membrane phospholipid composition in mammalian brain can be modified either by nutrients such as dietary fatty acids, or by certain toxic substances such as methylmercury (MeHg), leading to various biological and toxic effects. The present study evaluated the effects of eicosapentaenoic acid (EPA) and MeHg on the composition of the two most abundant membrane phospholipid classes, i.e., phosphatidylcholines (PtdCho) and phosphatidylethanolamines (PtdEtn), in mouse brain by using a two-level factorial design. The intact membrane PtdCho and PtdEtn species were analyzed by liquid chromatography-mass spectrometry. The effects of EPA and MeHg on the PtdCho and PtdEtn composition were evaluated by principal component analysis and ANOVA. The results showed that EPA and MeHg had different effects on the composition of membrane PtdCho and PtdEtn species in brain, where EPA showed strongest impact. EPA led to large reductions in the levels of arachidonic acid (ARA)-containing PtdCho and PtdEtn species in brain, while MeHg tended to elevate the levels of ARA-containing PtdCho and PtdEtn species. EPA also significantly increased the levels of PtdCho and PtdEtn species with n-3 fatty acids. Our results indicate that EPA may to some degree counteract the alterations of the PtdCho and PtdEtn pattern induced by MeHg, and thus alleviate the MeHg neurotoxicity in mouse brain through the inhibition of ARA-derived pro-inflammatory factors. These results may assist in the understanding of the interaction between MeHg, EPA and phospholipids, as well as the risk and benefits of a fish diet.


Assuntos
Ácido Araquidônico/metabolismo , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Ácido Eicosapentaenoico/farmacologia , Compostos de Metilmercúrio/farmacologia , Fosfolipídeos/química , Fosfolipídeos/metabolismo , Animais , Suplementos Nutricionais , Ácido Eicosapentaenoico/administração & dosagem , Ácido Eicosapentaenoico/química , Masculino , Compostos de Metilmercúrio/administração & dosagem , Compostos de Metilmercúrio/química , Camundongos , Camundongos Endogâmicos C57BL
3.
Am J Physiol Endocrinol Metab ; 302(9): E1097-112, 2012 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-22338077

RESUMO

Fish oil rich in n-3 polyunsaturated fatty acids is known to attenuate diet-induced obesity and adipose tissue inflammation in rodents. Here we aimed to investigate whether different carbohydrate sources modulated the antiobesity effects of fish oil. By feeding C57BL/6J mice isocaloric high-fat diets enriched with fish oil for 6 wk, we show that increasing amounts of sucrose in the diets dose-dependently increased energy efficiency and white adipose tissue (WAT) mass. Mice receiving fructose had about 50% less WAT mass than mice fed a high fish oil diet supplemented with either glucose or sucrose, indicating that the glucose moiety of sucrose was responsible for the obesity-promoting effect of sucrose. To investigate whether the obesogenic effect of sucrose and glucose was related to stimulation of insulin secretion, we combined fish oil with high and low glycemic index (GI) starches. Mice receiving the fish oil diet containing the low-GI starch had significantly less WAT than mice fed high-GI starch. Moreover, inhibition of insulin secretion by administration of nifedipine significantly reduced WAT mass in mice fed a high-fish oil diet in combination with sucrose. Our data show that the macronutrient composition of the diet modulates the effects of fish oil. Fish oil combined with sucrose, glucose, or high-GI starch promotes obesity, and the reported anti-inflammatory actions of fish oil are abrogated. In conclusion, our data indicate that glycemic control of insulin secretion modulates metabolic effects of fish oil by demonstrating that high-GI carbohydrates attenuate the antiobesity effects of fish oil.


Assuntos
Fármacos Antiobesidade/uso terapêutico , Carboidratos da Dieta/metabolismo , Óleos de Peixe/uso terapêutico , Índice Glicêmico/fisiologia , Insulina/sangue , Obesidade/metabolismo , Animais , Fármacos Antiobesidade/metabolismo , Relação Dose-Resposta a Droga , Óleos de Peixe/metabolismo , Glucose , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Obesidade/induzido quimicamente , Obesidade/prevenção & controle , Sacarose
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA